Skip to main content
Laura Esserman, MD, General Surgery, San Francisco, CA, UCSF Medical Center

LauraJ.EssermanMD

General Surgery San Francisco, CA

Surgical Oncology (Other than Breast)

Associate Professor of Surgery, UCSF

Dr. Esserman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Esserman's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 1983 - 1991
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1984 - 2026
  • HI State Medical License
    HI State Medical License 1989 - 1990
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients  
    Merisa Piper, Jasmine Wong, Hani Sbitany, Cheryl Ewing, Michael Alvarado, Laura Esserman, Robert Foster, Annals of Surgical Oncology

Lectures

  • The Role of Molecular Biomarkers in the Treatment of the High Risk Patient/I-SPY Trail 
    San Francisco, CA - 10/25/2014

Other

Press Mentions

  • Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-sPY2 TRIAL at ASCO
    Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-sPY2 TRIAL at ASCOMay 1st, 2023
  • AACR Names Fellows of the AACR Academy Class of 2023
    AACR Names Fellows of the AACR Academy Class of 2023April 7th, 2023
  • AACR Announces Fellows of the AACR Academy Class of 2023 and New AACR Academy President
    AACR Announces Fellows of the AACR Academy Class of 2023 and New AACR Academy PresidentApril 6th, 2023
  • Join now to see all

Grant Support

  • Integrated Biomarkers To Characterize Breast Cancer RiskNational Cancer Institute2004–2009

Professional Memberships

Hospital Affiliations